Results 141 to 150 of about 13,787 (194)

SLPI in Prostate Cancer. [PDF]

Cancers (Basel)
Rosini D, Cosi I, De Iaco P, Sebastianelli A, Di Stefano G, Serni S, Nesi G, Notaro R, De Angioletti M.   +8 more
europepmc   +1 more source

The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma. [PDF]

Oncoscience
Rathod G, Parmar P.
europepmc   +1 more source

Characterization of Ets-1 deficiency-induced depigmentation in a mouse model: insights into vitiligo pathogenesis. [PDF]

Lab Anim Res
Chang WY, Tai TS, Lin YC, Chen PH, Chang CY, Su YC, Kao YH.   +6 more
europepmc   +1 more source

SCAMP3-Driven Regulation of ERK1/2 and Autophagy Phosphoproteomics Signatures in Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Morales-Cabán BM, Cantres-Rosario YM, Tosado-Rodríguez EL, Roche-Lima A, Meléndez LM, Boukli NM, Suarez-Arroyo IJ.   +6 more
europepmc   +1 more source

Ets1 represses Blimp1 to promote germinal center T follicular helper cell differentiation during viral infection. [PDF]

J Immunol
Perkins B, Fuchs B, Nguyen NX, Williams MA, Hale JS.   +4 more
europepmc   +1 more source

SPDEF downregulation promotes tumor aggressiveness and poor prognosis in triple-negative breast cancer. [PDF]

Transl Cancer Res
Wei C, Liu Q, Wang H, Liu X.
europepmc   +1 more source

SOX8 mediates the crosstalk between KRAS and TGF-β pathways to promote the malignant progression of pancreatic cancer. [PDF]

Am J Cancer Res
Chiba N, Kojima H, Suda R, Nakagawa M, Ochiai S, Gunji T, Sano T, Tabuchi S, Ishizaki T, Kawachi S.   +9 more
europepmc   +1 more source

ETS-1 in tumor immunology: implications for novel anti-cancer strategies. [PDF]

Front Immunol
Wang S, Wan L, Zhang X, Fang H, Zhang M, Li F, Yan D.   +6 more
europepmc   +1 more source